Inserm, Research Unit 695, 16, rue Henri-Huchard, 75018 Paris, France.
Diabetes Metab. 2013 May;39(3):263-70. doi: 10.1016/j.diabet.2012.11.004. Epub 2013 Jan 23.
Vitamin D deficiency is associated with coronary artery disease (CAD), and the actions of vitamin D are mediated by binding to a specific nuclear vitamin D receptor (VDR). This study investigated the associations of VDR gene variants with CAD in two cohorts of type 2 diabetes patients.
A cohort of 3137 subjects from the prospective DIABHYCAR study (CAD incidence: 14.8%; follow-up: 4.4 ± 1.3 years) and an independent, hospital-based population of 713 subjects, 32.3% of whom had CAD, were assessed. Three SNPs in the VDR gene were genotyped: rs1544410 (BsmI); rs7975232 (ApaI); and rs731236 (TaqI).
In the DIABHYCAR cohort, an association was observed between the A allele of BsmI and incident cases of CAD (HR: 1.16, 95% CI: 1.05-1.29; P = 0.002). Associations were also observed between BsmI (P = 0.01) and TaqI (P = 0.04) alleles and baseline cases of CAD. The AAC haplotype (BsmI/ApaI/TaqI) was significantly associated with an increased CAD prevalence at the end of the study compared with the GCT haplotype (OR: 1.12, 95% CI: 1.02-1.28; P = 0.04). In a cross-sectional study of the independent hospital-based cohort, associations of ApaI (P = 0.009) and TaqI (P = 0.03) alleles with CAD were observed, with similar haplotype results (OR: 1.33, 95% CI: 1.03-1.73; P = 0.03).
The haplotype comprising the minor allele of BsmI, major allele of ApaI and minor allele of TaqI of VDR (AAC) was associated with an increased risk of CAD in type 2 diabetes patients. This effect was independent of the effects of other known cardiovascular risk factors.
维生素 D 缺乏与冠状动脉疾病(CAD)有关,而维生素 D 的作用是通过与特定的核维生素 D 受体(VDR)结合来介导的。本研究在两批 2 型糖尿病患者队列中研究了 VDR 基因变异与 CAD 的相关性。
前瞻性 DIABHYCAR 研究中的 3137 名受试者队列(CAD 发生率:14.8%;随访:4.4±1.3 年)和一个独立的、基于医院的 713 名受试者队列,其中 32.3%患有 CAD,对他们进行了评估。对 VDR 基因中的三个 SNP 进行了基因分型:rs1544410(BsmI);rs7975232(ApaI);和 rs731236(TaqI)。
在 DIABHYCAR 队列中,BsmI 的 A 等位基因与 CAD 的发病病例相关(HR:1.16,95%CI:1.05-1.29;P=0.002)。BsmI(P=0.01)和 TaqI(P=0.04)等位基因与基线 CAD 病例之间也存在关联。与 GCT 单倍型相比,AAC 单倍型(BsmI/ApaI/TaqI)在研究结束时与更高的 CAD 患病率显著相关(OR:1.12,95%CI:1.02-1.28;P=0.04)。在独立的基于医院的队列的横断面研究中,观察到 ApaI(P=0.009)和 TaqI(P=0.03)等位基因与 CAD 相关,并且存在相似的单倍型结果(OR:1.33,95%CI:1.03-1.73;P=0.03)。
VDR(BsmI 中的次要等位基因、ApaI 的主要等位基因和 TaqI 的次要等位基因)组成的单倍型与 2 型糖尿病患者 CAD 的风险增加相关。这种作用独立于其他已知心血管危险因素的作用。